| PERIOD ENDING | 1-Aug-09 | 2-May-09 | 31-Jan-09 | 1-Nov-08 | | Total Revenue | 122,443 | 118,169 | 164,035 | 110,952 | | Cost of Revenue | 86,321 | 82,892 | 110,786 | 81,876 | | | Gross Profit | 36,122 | 35,277 | 53,249 | 29,076 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 29,911 | 28,168 | 29,981 | 28,320 | | Non Recurring |
-
|
-
| 1,351 |
-
| | Others | 3,604 | 3,583 | 3,767 | 3,613 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 2,607 | 3,526 | 18,150 | (2,857) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1) | 1 |
-
|
-
| | Earnings Before Interest And Taxes | 2,606 | 3,527 | 18,150 | (2,857) | | Interest Expense | 141 | 178 | 299 | 627 | | Income Before Tax | 2,465 | 3,349 | 17,851 | (3,484) | | Income Tax Expense | 956 | 1,291 | 6,642 | (1,298) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,509 | 2,058 | 11,209 | (2,186) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,509 | 2,058 | 11,209 | (2,186) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,509 | $2,058 | $11,209 | ($2,186) |
|
0.36% Nasdaq 
0.25%
Income Statement
